Response to Temozolomide in Patients With Metastatic Colorectal Cancer With Loss of MGMT Expression: A New Approach in the Era of Personalized Medicine?-Reference-Cited by-同舟云学术

Response to Temozolomide in Patients With Metastatic Colorectal Cancer With Loss of MGMT Expression: A New Approach in the Era of Personalized Medicine?

Published:2011-04-01 Issue:10 Volume:29 Page:e262-e265
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Shacham-Shmueli Einat¹,Beny Alexander²,Geva Ravit¹,Blachar Arye¹,Figer Arie¹,Aderka Dan³

Affiliation:

1. Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

2. Rambam Medical Center, Haifa, Israel

3. Chaim Sheba Medical Center, Tel-Hashomer, Israel

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.32.0242

Reference14 articles.

1. OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

2. Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

3. Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

4. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in gastrointestinal cancers;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-21

2. BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death;Cell Communication and Signaling;2022-12-27

3. Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer;Cancer Treatment Reviews;2020-01

4. Clinical importance of DNA repair in sporadic colorectal cancer;Critical Reviews in Oncology/Hematology;2018-06

5. A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer;Cancer;2018-03-26